February 20, 2019
UC San Diego Health is among 31 health facilities selected from across the state to participate in the California Bridge Program, an accelerated, 18-month training program for health care providers to enhance access to around-the-clock treatment for patients with opioid use disorder.
February 29, 2016
Rising above Interstate 5 on the east campus of University of California, San Diego, the Altman Clinical and Translational Research Institute Building (ACTRI), a five-sided polygon of glass, steel and grooved concrete, officially opens its doors March 4 in a ribbon-cutting ceremony.
March 12, 2019
U.S. News & World Report today released its 2020 guidebook that ranks the nation’s top graduate programs and professional schools, giving high marks to UC San Diego’s innovative programs.
May 26, 2016
Not all habits are bad. Some are even necessary. But inability to switch from acting habitually to acting in a deliberate way can underlie addiction and obsessive compulsive disorders. Working with a mouse model, an international team of researchers demonstrates what happens in the brain for habits to control behavior
January 14, 2019
An international group that includes researchers at University of California San Diego School of Medicine has identified 124 genetic variants associated with a person’s willingness to take risks, as reported in a study published January 14, 2019 in Nature Genetics.
April 16, 2019
The University of California San Diego School of Global Policy and Strategy’s Center for U.S.-Mexican Studies recently released a report listing steps the U.S. and Mexico can take to make each other safe. The white paper lists 13 recommendations for both nations to achieve bilateral cooperation.
March 10, 2016
…Study, the Center for Cannabis Research, the Type 1 Diabetes Research Center, the Musculoskeletal Science Center, the Center for Multimodal Imaging and Genomics and the departments of gastroenterology, hepatology and ophthalmology. “This is a 21st century lab,” said Dr. David Brenner, Vice Chancellor of Health Sciences and Dean of the…
June 10, 2024
Americans’ interest in the potentially harmful “magic mushroom” Amanita muscaria is soaring, according to a new study. UC San Diego researchers suggest the market growth may be driven by clinical research on psilocybin’s safety and efficacy in treating depression.
April 18, 2019
…on HIV and medicinal cannabis. Read More… Nineteen-hundred-and-sixty-nine was a famously memorable year. It was the year of Woodstock and the first man on the moon, of the Cuyahoga River in Cleveland catching fire and the last public performance by The Beatles—an impromptu concert atop Apple Records in London. It…
September 25, 2012
Researchers at University of California, San Diego Moores Cancer Center are evaluating the safety and tolerability of a synthetic cannabinoid called dexanabinol (ETS2101). Delivered as a weekly intravenous infusion, the drug is being tested in patients with all forms of brain cancer, both primary and metastatic.
